307 related articles for article (PubMed ID: 22178272)
1. ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse.
Paillot R; Prowse L
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):516-21. PubMed ID: 22178272
[TBL] [Abstract][Full Text] [Related]
2. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
Paillot R; Grimmett H; Elton D; Daly JM
Vet Res; 2008; 39(3):21. PubMed ID: 18252187
[TBL] [Abstract][Full Text] [Related]
3. Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity.
Paillot R; Prowse L; Montesso F; Huang CM; Barnes H; Escala J
Vet Microbiol; 2013 Mar; 162(2-4):396-407. PubMed ID: 23146168
[TBL] [Abstract][Full Text] [Related]
4. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
Paillot R; Kydd JH; Sindle T; Hannant D; Edlund Toulemonde C; Audonnet JC; Minke JM; Daly JM
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):225-33. PubMed ID: 16621023
[TBL] [Abstract][Full Text] [Related]
5. Humoral response and antiviral cytokine expression following vaccination of thoroughbred weanlings--a blinded comparison of commercially available vaccines.
Gildea S; Quinlivan M; Murphy BA; Cullinane A
Vaccine; 2013 Oct; 31(45):5216-22. PubMed ID: 24021309
[TBL] [Abstract][Full Text] [Related]
6. Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix.
Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
Vaccine; 2010 Oct; 28(43):6989-96. PubMed ID: 20728523
[TBL] [Abstract][Full Text] [Related]
7. New assays to measure equine influenza virus-specific Type 1 immunity in horses.
Paillot R; Kydd JH; MacRae S; Minke JM; Hannant D; Daly JM
Vaccine; 2007 Oct; 25(42):7385-98. PubMed ID: 17881098
[TBL] [Abstract][Full Text] [Related]
8. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
[TBL] [Abstract][Full Text] [Related]
9. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap.
Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
Vaccine; 2009 Sep; 27(40):5530-7. PubMed ID: 19607950
[TBL] [Abstract][Full Text] [Related]
10. The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses.
Crouch CF; Daly J; Henley W; Hannant D; Wilkins J; Francis MJ
Vet Immunol Immunopathol; 2005 Dec; 108(3-4):345-55. PubMed ID: 16098611
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.
Paillot R; Prowse L; Donald C; Medcalf E; Montesso F; Bryant N; Watson J; Jeggo M; Elton D; Newton R; Trail P; Barnes H
Vet Immunol Immunopathol; 2010 Aug; 136(3-4):272-83. PubMed ID: 20400185
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
[TBL] [Abstract][Full Text] [Related]
13. Humoral and cell-mediated immune responses of old horses following recombinant canarypox virus vaccination and subsequent challenge infection.
Adams AA; Sturgill TL; Breathnach CC; Chambers TM; Siger L; Minke JM; Horohov DW
Vet Immunol Immunopathol; 2011 Feb; 139(2-4):128-40. PubMed ID: 21035197
[TBL] [Abstract][Full Text] [Related]
14. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
Lopez AM; Hecker R; Mutwiri G; van Drunen Littel-van den Hurk S; Babiuk LA; Townsend HG
Vet Immunol Immunopathol; 2006 Nov; 114(1-2):103-10. PubMed ID: 16950519
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
[TBL] [Abstract][Full Text] [Related]
16. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study.
Gildea S; Arkins S; Walsh C; Cullinane A
Vaccine; 2011 May; 29(22):3917-22. PubMed ID: 21419776
[TBL] [Abstract][Full Text] [Related]
17. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.
Gildea S; Arkins S; Walsh C; Cullinane A
Vaccine; 2011 Nov; 29(49):9214-23. PubMed ID: 21983355
[TBL] [Abstract][Full Text] [Related]
18. Concurrent vaccination against equine influenza and equine herpesvirus - a practical approach.
Gildea S; Sanchez Higgins MJ; Johnson G; Walsh C; Cullinane A
Influenza Other Respir Viruses; 2016 Sep; 10(5):433-7. PubMed ID: 27169603
[TBL] [Abstract][Full Text] [Related]
19. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
[TBL] [Abstract][Full Text] [Related]
20. Equine Influenza Virus and Vaccines.
Oladunni FS; Oseni SO; Martinez-Sobrido L; Chambers TM
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
